Literature DB >> 28559769

Next-Generation Sequencing Reveals a Nonsense Mutation (p.Arg364Ter) in MRE11A Gene in an Indian Patient with Familial Breast Cancer.

Pratibha Sharma Bhai1, Deepak Sharma2, Renu Saxena1, Ishwar C Verma1.   

Abstract

BACKGROUND: The MRN complex consisting of MRE11A-RAD50-NBS1 proteins is involved in the repair of double-strand breaks, and mutations in genes coding for the MRN complex have been identified in families with breast and ovarian cancer. CASE REPORT: In a BRCA-negative family with positive history of breast and endometrial cancer, next-generation sequencing-based panel testing identified a mutation in the MRE11A gene (NM_005590 c.1090C>T: p.Arg364Ter). This mutation results in a shorter mutated protein lacking 2 DNA binding domains (the GAR domain and the RAD50 binding site), abolishing the function of protein.
CONCLUSION: This case provides insight into the role of the MRE11A gene in causing breast cancer susceptibility in families, and supports the use of multigene panel testing in cases with hereditary predisposition to breast cancer.

Entities:  

Keywords:  <italic>MRE11</italic>; Breast cancer; Next-generation sequencing

Year:  2017        PMID: 28559769      PMCID: PMC5447174          DOI: 10.1159/000457786

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN: 1661-3791            Impact factor:   2.860


  24 in total

1.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

2.  Detection of novel germline mutations for breast cancer in non-BRCA1/2 families.

Authors:  Fatima Aloraifi; Trudi McDevitt; Rui Martiniano; Jonah McGreevy; Russell McLaughlin; Chris M Egan; Nuala Cody; Marie Meany; Elaine Kenny; Andrew J Green; Daniel G Bradley; James G Geraghty; Adrian P Bracken
Journal:  FEBS J       Date:  2015-07-14       Impact factor: 5.542

3.  Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.

Authors:  Suresh Hedau; Neeraj Jain; Syed A Husain; Ashish K Mandal; Gibanananda Ray; M Shahid; Ravi Kant; Vishal Gupta; Nootan K Shukla; Suryanarayan S V Deo; Bhudev C Das
Journal:  Breast Cancer Res Treat       Date:  2004-11       Impact factor: 4.872

Review 4.  Envisioning the dynamics and flexibility of Mre11-Rad50-Nbs1 complex to decipher its roles in DNA replication and repair.

Authors:  Julien Lafrance-Vanasse; Gareth J Williams; John A Tainer
Journal:  Prog Biophys Mol Biol       Date:  2015-01-07       Impact factor: 3.667

5.  Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes.

Authors:  Laurent Castéra; Sophie Krieger; Antoine Rousselin; Angélina Legros; Jean-Jacques Baumann; Olivia Bruet; Baptiste Brault; Robin Fouillet; Nicolas Goardon; Olivier Letac; Stéphanie Baert-Desurmont; Julie Tinat; Odile Bera; Catherine Dugast; Pascaline Berthet; Florence Polycarpe; Valérie Layet; Agnes Hardouin; Thierry Frébourg; Dominique Vaur
Journal:  Eur J Hum Genet       Date:  2014-02-19       Impact factor: 4.246

6.  Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing gene.

Authors:  Jirina Bartkova; Johanna Tommiska; Lenka Oplustilova; Kirsimari Aaltonen; Anitta Tamminen; Tuomas Heikkinen; Martin Mistrik; Kristiina Aittomäki; Carl Blomqvist; Päivi Heikkilä; Jiri Lukas; Heli Nevanlinna; Jiri Bartek
Journal:  Mol Oncol       Date:  2008-10-07       Impact factor: 6.603

7.  Role of MRE11 in cell proliferation, tumor invasion, and DNA repair in breast cancer.

Authors:  Shyng-Shiou F Yuan; Ming-Feng Hou; Ya-Ching Hsieh; Chien-Yiu Huang; Yi-Chen Lee; Yun-Ju Chen; Steven Lo
Journal:  J Natl Cancer Inst       Date:  2012-08-22       Impact factor: 13.506

Review 8.  Genetic susceptibility to breast cancer.

Authors:  Angela R Bradbury; Olufunmilayo I Olopade
Journal:  Rev Endocr Metab Disord       Date:  2007-05-17       Impact factor: 6.514

9.  Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients.

Authors:  Holly LaDuca; A J Stuenkel; Jill S Dolinsky; Steven Keiles; Stephany Tandy; Tina Pesaran; Elaine Chen; Chia-Ling Gau; Erika Palmaer; Kamelia Shoaepour; Divya Shah; Virginia Speare; Stephanie Gandomi; Elizabeth Chao
Journal:  Genet Med       Date:  2014-04-24       Impact factor: 8.822

10.  Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast-ovarian cancer families.

Authors:  Mani T Valarmathi; Meenakshi Sawhney; Suryanarayana S V Deo; Nootan K Shukla; Satya N Das
Journal:  Hum Mutat       Date:  2004-02       Impact factor: 4.878

View more
  1 in total

1.  Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients.

Authors:  Lauren G Aoude; Vanessa F Bonazzi; Sandra Brosda; Kalpana Patel; Lambros T Koufariotis; Harald Oey; Katia Nones; Scott Wood; John V Pearson; James M Lonie; Melissa Arneil; Victoria Atkinson; B Mark Smithers; Nicola Waddell; Andrew P Barbour
Journal:  Sci Rep       Date:  2020-10-19       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.